BMI Korea is a South Korean CDMO offering contract development and manufacturing services spanning small molecule APIs, oral solid dosage forms, biologics, vaccines, and mRNA products. The company provides integrated services from formulation development through commercial-scale manufacturing with cGMP-compliant facilities.
Biologics manufacturing, small molecule drug product, mRNA production, vaccines, oral solid dose
1 site worldwide
No reviews available yet.
No documents available.